{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T04:22:24Z","timestamp":1775881344503,"version":"3.50.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2007,5,17]],"date-time":"2007-05-17T00:00:00Z","timestamp":1179360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,5,17]],"date-time":"2007-05-17T00:00:00Z","timestamp":1179360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1038\/sj.leu.2404720","type":"journal-article","created":{"date-parts":[[2007,5,17]],"date-time":"2007-05-17T13:24:56Z","timestamp":1179408296000},"page":"1451-1459","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["CTLA-4 blockade in murine bone marrow chimeras induces a host-derived antileukemic effect without graft-versus-host disease"],"prefix":"10.1038","volume":"21","author":[{"given":"S","family":"Fevery","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A D","family":"Billiau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Sprangers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Rutgeerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Lenaerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Goebels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Landuyt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Kasran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Boon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"Sagaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"De Wolf-Peeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Waer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,5,17]]},"reference":[{"key":"BF2404720_CR1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","volume":"75","author":"MM Horowitz","year":"1990","unstructured":"Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555\u2013562.","journal-title":"Blood"},{"key":"BF2404720_CR2","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1056\/NEJM197905103001902","volume":"300","author":"PL Weiden","year":"1979","unstructured":"Weiden PL, Flournoy N, Thomas ED, Prentice R, Fefer A, Buckner CD et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med 1979; 300: 1068\u20131073.","journal-title":"N Engl J Med"},{"key":"BF2404720_CR3","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1182\/blood.V94.9.3234","volume":"94","author":"R Childs","year":"1999","unstructured":"Childs R, Clave E, Contentin N, Jayasekera D, Hensel N, Leitman S et al. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses. Blood 1999; 94: 3234\u20133241.","journal-title":"Blood"},{"key":"BF2404720_CR4","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1182\/blood-2002-02-0419","volume":"100","author":"AD Billiau","year":"2002","unstructured":"Billiau AD, Fevery S, Rutgeerts O, Landuyt W, Waer M . Crucial role of timing of donor lymphocyte infusion in generating dissociated graft-versus-host and graft-versus-leukemia responses in mice receiving allogeneic bone marrow transplants. Blood 2002; 100: 1894\u20131902.","journal-title":"Blood"},{"key":"BF2404720_CR5","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1182\/blood-2002-01-0023","volume":"100","author":"MY Mapara","year":"2002","unstructured":"Mapara MY, Kim YM, Wang SP, Bronson R, Sachs DH, Sykes M . Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells. Blood 2002; 100: 1903\u20131909.","journal-title":"Blood"},{"key":"BF2404720_CR6","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1182\/blood.V93.7.2336","volume":"93","author":"T Mutis","year":"1999","unstructured":"Mutis T, Verdijk R, Schrama E, Esendam B, Brand A, Goulmy E . Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens. Blood 1999; 93: 2336\u20132341.","journal-title":"Blood"},{"key":"BF2404720_CR7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nrc1365","volume":"4","author":"M Bleakley","year":"2004","unstructured":"Bleakley M, Riddell SR . Molecules and mechanisms of the graft-versus-leukaemia effect. Nat Rev Cancer 2004; 4: 371\u2013380.","journal-title":"Nat Rev Cancer"},{"key":"BF2404720_CR8","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1182\/blood.V87.9.3587.bloodjournal8793587","volume":"87","author":"M Bocchia","year":"1996","unstructured":"Bocchia M, Korontsvit T, Xu Q, Mackinnon S, Yang SY, Sette A et al. Specific human cellular immunity to bcr-abl oncogene-derived peptides. Blood 1996; 87: 3587\u20133592.","journal-title":"Blood"},{"key":"BF2404720_CR9","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1182\/blood.V91.8.2925.2925_2925_2934","volume":"91","author":"MA Roskrow","year":"1998","unstructured":"Roskrow MA, Suzuki N, Gan Y, Sixbey JW, Ng CY, Kimbrough S et al. Epstein\u2013Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease. Blood 1998; 91: 2925\u20132934.","journal-title":"Blood"},{"key":"BF2404720_CR10","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nm0904-887","volume":"10","author":"D Pardoll","year":"2004","unstructured":"Pardoll D, Allison J . Cancer immunotherapy: breaking the barriers to harvest the crop. Nat Med 2004; 10: 887\u2013892.","journal-title":"Nat Med"},{"key":"BF2404720_CR11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev.immunol.19.1.225","volume":"19","author":"B Salomon","year":"2001","unstructured":"Salomon B, Bluestone JA . Complexities of CD28\/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 2001; 19: 225\u2013252.","journal-title":"Annu Rev Immunol"},{"key":"BF2404720_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1182\/blood-2004-04-1596","volume":"105","author":"JL Riley","year":"2005","unstructured":"Riley JL, June CH . The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation. Blood 2005; 105: 13\u201321.","journal-title":"Blood"},{"key":"BF2404720_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/1074-7613(95)90125-6","volume":"3","author":"EA Tivol","year":"1995","unstructured":"Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH . Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995; 3: 541\u2013547.","journal-title":"Immunity"},{"key":"BF2404720_CR14","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1126\/science.270.5238.985","volume":"270","author":"P Waterhouse","year":"1995","unstructured":"Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP et al. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 1995; 270: 985\u2013988.","journal-title":"Science"},{"key":"BF2404720_CR15","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S1074-7613(00)80406-9","volume":"7","author":"CA Chambers","year":"1997","unstructured":"Chambers CA, Sullivan TJ, Allison JP . Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells. Immunity 1997; 7: 885\u2013895.","journal-title":"Immunity"},{"key":"BF2404720_CR16","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1084\/jem.184.2.783","volume":"184","author":"NJ Karandikar","year":"1996","unstructured":"Karandikar NJ, Vanderlugt CL, Walunas TL, Miller SD, Bluestone JA . CTLA-4: a negative regulator of autoimmune disease. J Exp Med 1996; 184: 783\u2013788.","journal-title":"J Exp Med"},{"key":"BF2404720_CR17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1084\/jem.187.3.427","volume":"187","author":"F Luhder","year":"1998","unstructured":"Luhder F, Hoglund P, Allison JP, Benoist C, Mathis D . Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J Exp Med 1998; 187: 427\u2013432.","journal-title":"J Exp Med"},{"key":"BF2404720_CR18","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1126\/science.271.5256.1734","volume":"271","author":"DR Leach","year":"1996","unstructured":"Leach DR, Krummel MF, Allison JP . Enhancement of antitumor immunity by CTLA-4 blockade. Science 1996; 271: 1734\u20131736.","journal-title":"Science"},{"key":"BF2404720_CR19","doi-asserted-by":"publisher","first-page":"8099","DOI":"10.1073\/pnas.94.15.8099","volume":"94","author":"ED Kwon","year":"1997","unstructured":"Kwon ED, Hurwitz AA, Foster BA, Madias C, Feldhaus AL, Greenberg NM et al. Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer. Proc Natl Acad Sci USA 1997; 94: 8099\u20138103.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2404720_CR20","doi-asserted-by":"publisher","first-page":"11476","DOI":"10.1073\/pnas.96.20.11476","volume":"96","author":"EM Sotomayor","year":"1999","unstructured":"Sotomayor EM, Borrello I, Tubb E, Allison JP, Levitsky HI . In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance. Proc Natl Acad Sci USA 1999; 96: 11476\u201311481.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2404720_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1084\/jem.194.4.481","volume":"194","author":"A van Elsas","year":"2001","unstructured":"van Elsas A, Sutmuller RP, Hurwitz AA, Ziskin J, Villasenor J, Medema JP et al. Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapy. J Exp Med 2001; 194: 481\u2013489.","journal-title":"J Exp Med"},{"key":"BF2404720_CR22","first-page":"2444","volume":"60","author":"AA Hurwitz","year":"2000","unstructured":"Hurwitz AA, Foster BA, Kwon ED, Truong T, Choi EM, Greenberg NM et al. Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade. Cancer Res 2000; 60: 2444\u20132448.","journal-title":"Cancer Res"},{"key":"BF2404720_CR23","first-page":"5301","volume":"58","author":"MB Mokyr","year":"1998","unstructured":"Mokyr MB, Kalinichenko T, Gorelik L, Bluestone JA . Realization of the therapeutic potential of CTLA-4 blockade in low-dose chemotherapy-treated tumor-bearing mice. Cancer Res 1998; 58: 5301\u20135304.","journal-title":"Cancer Res"},{"key":"BF2404720_CR24","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1073\/pnas.0830997100","volume":"100","author":"FS Hodi","year":"2003","unstructured":"Hodi FS, Mihm MC, Soiffer RJ, Haluska FG, Butler M, Seiden MV et al. Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc Natl Acad Sci USA 2003; 100: 4712\u20134717.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2404720_CR25","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1200\/JCO.2005.01.128","volume":"23","author":"K Sanderson","year":"2005","unstructured":"Sanderson K, Scotland R, Lee P, Liu D, Groshen S, Snively J et al. Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma. J Clin Oncol 2005; 23: 741\u2013750.","journal-title":"J Clin Oncol"},{"key":"BF2404720_CR26","doi-asserted-by":"publisher","first-page":"6043","DOI":"10.1200\/JCO.2005.06.205","volume":"23","author":"P Attia","year":"2005","unstructured":"Attia P, Phan GQ, Maker AV, Robinson MR, Quezado MM, Yang JC et al. Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. J Clin Oncol 2005; 23: 6043\u20136053.","journal-title":"J Clin Oncol"},{"key":"BF2404720_CR27","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/01.cji.0000178913.41256.06","volume":"28","author":"JA Blansfield","year":"2005","unstructured":"Blansfield JA, Beck KE, Tran K, Yang JC, Hughes MS, Kammula US et al. Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer. J Immunother 2005; 28: 593\u2013598.","journal-title":"J Immunother"},{"key":"BF2404720_CR28","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.4049\/jimmunol.162.11.6368","volume":"162","author":"BR Blazar","year":"1999","unstructured":"Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Sharpe AH, Vallera DA . Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells. J Immunol 1999; 162: 6368\u20136377.","journal-title":"J Immunol"},{"key":"BF2404720_CR29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1034\/j.1399-0039.2003.00096.x","volume":"61","author":"CK Hurley","year":"2003","unstructured":"Hurley CK, Fernandez VM, Setterholm M . Maximizing optimal hematopoietic stem cell donor selection from registries of unrelated adult volunteers. Tissue Antigens 2003; 61: 415\u2013424.","journal-title":"Tissue Antigens"},{"key":"BF2404720_CR30","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/00007890-200007270-00020","volume":"70","author":"H Sefrioui","year":"2000","unstructured":"Sefrioui H, Billiau AD, Waer M . Graft-versus-leukemia effect in minor antigen mismatched chimeras given delayed donor leucocyte infusion: immunoregulatory aspects and role of donor T and ASGM1-positive cells. Transplantation 2000; 70: 348\u2013353.","journal-title":"Transplantation"},{"key":"BF2404720_CR31","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1097\/00007890-199603150-00025","volume":"61","author":"A Salam","year":"1996","unstructured":"Salam A, Waer M . Graft-versus-host reactivity and graft-versus-leukemia effect in murine allogeneic bone marrow chimeras conditioned with total body irradiation or total lymphoid irradiation. Transplantation 1996; 61: 826\u2013830.","journal-title":"Transplantation"},{"key":"BF2404720_CR32","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1182\/blood.V92.10.3949","volume":"92","author":"BR Blazar","year":"1998","unstructured":"Blazar BR, Taylor PA, McElmurry R, Tian L, Panoskaltsis-Mortari A, Lam S et al. Engraftment of severe combined immune deficient mice receiving allogeneic bone marrow via in utero or postnatal transfer. Blood 1998; 92: 3949\u20133959.","journal-title":"Blood"},{"key":"BF2404720_CR33","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1172\/JCI200316950","volume":"111","author":"YM Kim","year":"2003","unstructured":"Kim YM, Sachs T, Asavaroengchai W, Bronson R, Sykes M . Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720. J Clin Invest 2003; 111: 659\u2013669.","journal-title":"J Clin Invest"},{"key":"BF2404720_CR34","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1182\/blood.V92.10.3949","volume":"92","author":"BR Blazar","year":"1998","unstructured":"Blazar BR, Taylor PA, McElmurry R, Tian L, Panoskaltsis-Mortari A, Lam S et al. Engraftment of severe combined immune deficient mice receiving allogeneic bone marrow via in utero or postnatal transfer. Blood 1998; 92: 3949\u20133959.","journal-title":"Blood"},{"key":"BF2404720_CR35","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1172\/JCI119873","volume":"100","author":"AD Wells","year":"1997","unstructured":"Wells AD, Gudmundsdottir H, Turka LA . Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J Clin Invest 1997; 100: 3173\u20133183.","journal-title":"J Clin Invest"},{"key":"BF2404720_CR36","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jsbmb.2004.03.017","volume":"89\u201390","author":"E van Etten","year":"2004","unstructured":"van Etten E, Decallonne B, Bouillon R, Mathieu C . NOD bone marrow-derived dendritic cells are modulated by analogs of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol 2004; 89\u201390: 457\u2013459.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BF2404720_CR37","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.4049\/jimmunol.154.12.6602","volume":"154","author":"A Bonomo","year":"1995","unstructured":"Bonomo A, Kehn PJ, Payer E, Rizzo L, Cheever AW, Shevach EM . Pathogenesis of post-thymectomy autoimmunity. Role of syngeneic MLR-reactive T cells. J Immunol 1995; 154: 6602\u20136611.","journal-title":"J Immunol"},{"key":"BF2404720_CR38","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.4049\/jimmunol.166.3.1843","volume":"166","author":"G Xia","year":"2001","unstructured":"Xia G, Goebels J, Rutgeerts O, Vandeputte M, Waer M . Transplantation tolerance and autoimmunity after xenogeneic thymus transplantation. J Immunol 2001; 166: 1843\u20131854.","journal-title":"J Immunol"},{"key":"BF2404720_CR39","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jaut.2005.11.001","volume":"26","author":"P Lapierre","year":"2006","unstructured":"Lapierre P, Beland K, Djilali-Saiah I, Alvarez F . Type 2 autoimmune hepatitis murine model: the influence of genetic background in disease development. J Autoimmun 2006; 26: 82\u201389.","journal-title":"J Autoimmun"},{"key":"BF2404720_CR40","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1053\/jhep.2002.34944","volume":"36","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ, Freese DK . Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002; 36: 479\u2013497.","journal-title":"Hepatology"},{"key":"BF2404720_CR41","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1097\/00007890-198911000-00017","volume":"48","author":"WG Yasmineh","year":"1989","unstructured":"Yasmineh WG, Filipovich AH, Killeen AA . Serum 5\u2032nucleotidase and alkaline phosphatase\u2014highly predictive liver function tests for the diagnosis of graft-versus-host disease in bone marrow transplant recipients. Transplantation 1989; 48: 809\u2013814.","journal-title":"Transplantation"},{"key":"BF2404720_CR42","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jaut.2005.11.001","volume":"26","author":"P Lapierre","year":"2006","unstructured":"Lapierre P, Beland K, Djilali-Saiah I, Alvarez F . Type 2 autoimmune hepatitis murine model: the influence of genetic background in disease development. J Autoimmun 2006; 26: 82\u201389.","journal-title":"J Autoimmun"},{"key":"BF2404720_CR43","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1084\/jem.192.2.303","volume":"192","author":"T Takahashi","year":"2000","unstructured":"Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000; 192: 303\u2013310.","journal-title":"J Exp Med"},{"key":"BF2404720_CR44","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","volume":"86","author":"HJ Kolb","year":"1995","unstructured":"Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 86: 2041\u20132050.","journal-title":"Blood"},{"key":"BF2404720_CR45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1053\/j.seminhematol.2005.09.005","volume":"43","author":"D Porter","year":"2006","unstructured":"Porter D, Levine JE . Graft-versus-host disease and graft-versus-leukemia after donor leukocyte infusion. Semin Hematol 2006; 43: 53\u201361.","journal-title":"Semin Hematol"},{"key":"BF2404720_CR46","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1126\/science.285.5426.412","volume":"285","author":"WD Shlomchik","year":"1999","unstructured":"Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999; 285: 412\u2013415.","journal-title":"Science"},{"key":"BF2404720_CR47","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/nm1038","volume":"10","author":"M Merad","year":"2004","unstructured":"Merad M, Hoffmann P, Ranheim E, Slaymaker S, Manz MG, Lira SA et al. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat Med 2004; 10: 510\u2013517.","journal-title":"Nat Med"},{"key":"BF2404720_CR48","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/nm1309","volume":"11","author":"P Reddy","year":"2005","unstructured":"Reddy P, Maeda Y, Liu C, Krijanovski OI, Korngold R, Ferrara JL . A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses. Nat Med 2005; 11: 1244\u20131249.","journal-title":"Nat Med"},{"key":"BF2404720_CR49","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1182\/blood-2006-03-007427","volume":"108","author":"R Chakraverty","year":"2006","unstructured":"Chakraverty R, Eom HS, Sachs J, Buchli J, Cotter P, Hsu R et al. Host MHC Class II+ antigen-presenting cells and CD4 cells are required for CD8-mediated graft-versus-leukemia responses following delayed donor leukocyte infusions. Blood 2006; 108: 2106\u20132113. E-pub, 6 June 2006.","journal-title":"Blood"},{"key":"BF2404720_CR50","doi-asserted-by":"publisher","first-page":"665","DOI":"10.4049\/jimmunol.175.2.665","volume":"175","author":"MT Rubio","year":"2005","unstructured":"Rubio MT, Saito TI, Kattleman K, Zhao G, Buchli J, Sykes M . Mechanisms of the antitumor responses and host-versus-graft reactions induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: a critical role for recipient CD4+ T cells and recipient leukocyte infusion-derived IFN-gamma-producing CD8+ T cells. J Immunol 2005; 175: 665\u2013676.","journal-title":"J Immunol"},{"key":"BF2404720_CR51","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1365-2141.2004.05328.x","volume":"128","author":"BR Dey","year":"2005","unstructured":"Dey BR, McAfee S, Colby C, Cieply K, Caron M, Saidman S et al. Anti-tumour response despite loss of donor chimaerism in patients treated with non-myeloablative conditioning and allogeneic stem cell transplantation. Br J Haematol 2005; 128: 351\u2013359.","journal-title":"Br J Haematol"},{"key":"BF2404720_CR52","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1084\/jem.190.3.355","volume":"190","author":"A van Elsas","year":"1999","unstructured":"van Elsas A, Hurwitz AA, Allison JP . Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte\/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation. J Exp Med 1999; 190: 355\u2013366.","journal-title":"J Exp Med"},{"key":"BF2404720_CR53","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/00002371-200411000-00008","volume":"27","author":"MR Robinson","year":"2004","unstructured":"Robinson MR, Chan CC, Yang JC, Rubin BI, Gracia GJ, Sen HN et al. Cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma: a new cause of uveitis. J Immunother 2004; 27: 478\u2013479.","journal-title":"J Immunother"},{"key":"BF2404720_CR54","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1002\/eji.1830270811","volume":"27","author":"P Waterhouse","year":"1997","unstructured":"Waterhouse P, Bachmann MF, Penninger JM, Ohashi PS, Mak TW . Normal thymic selection, normal viability and decreased lymphoproliferation in T cell receptor-transgenic CTLA-4-deficient mice. Eur J Immunol 1997; 27: 1887\u20131892.","journal-title":"Eur J Immunol"},{"key":"BF2404720_CR55","doi-asserted-by":"publisher","first-page":"9296","DOI":"10.1073\/pnas.94.17.9296","volume":"94","author":"CA Chambers","year":"1997","unstructured":"Chambers CA, Cado D, Truong T, Allison JP . Thymocyte development is normal in CTLA-4-deficient mice. Proc Natl Acad Sci USA 1997; 94: 9296\u20139301.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2404720_CR56","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1084\/jem.188.7.1239","volume":"188","author":"CM Cilio","year":"1998","unstructured":"Cilio CM, Daws MR, Malashicheva A, Sentman CL, Holmberg D . Cytotoxic T lymphocyte antigen 4 is induced in the thymus upon in vivo activation and its blockade prevents anti-CD3-mediated depletion of thymocytes. J Exp Med 1998; 188: 1239\u20131246.","journal-title":"J Exp Med"},{"key":"BF2404720_CR57","doi-asserted-by":"publisher","first-page":"6645","DOI":"10.4049\/jimmunol.173.11.6645","volume":"173","author":"H Kwon","year":"2004","unstructured":"Kwon H, Jun HS, Khil LY, Yoon JW . Role of CTLA-4 in the activation of single- and double-positive thymocytes. J Immunol 2004; 173: 6645\u20136653.","journal-title":"J Immunol"},{"key":"BF2404720_CR58","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1084\/jem.192.2.295","volume":"192","author":"S Read","year":"2000","unstructured":"Read S, Malmstrom V, Powrie F . Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000; 192: 295\u2013302.","journal-title":"J Exp Med"},{"key":"BF2404720_CR59","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.4049\/jimmunol.168.3.1080","volume":"168","author":"CI Kingsley","year":"2002","unstructured":"Kingsley CI, Karim M, Bushell AR, Wood KJ . CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002; 168: 1080\u20131086.","journal-title":"J Immunol"},{"key":"BF2404720_CR60","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nri1027","volume":"3","author":"KJ Wood","year":"2003","unstructured":"Wood KJ, Sakaguchi S . Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199\u2013210.","journal-title":"Nat Rev Immunol"},{"key":"BF2404720_CR61","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/08830180590934976","volume":"24","author":"S Sakaguchi","year":"2005","unstructured":"Sakaguchi S, Sakaguchi N . Regulatory T cells in immunologic self-tolerance and autoimmune disease. Int Rev Immunol 2005; 24: 211\u2013226.","journal-title":"Int Rev Immunol"},{"key":"BF2404720_CR62","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1053\/j.seminhematol.2005.09.006","volume":"43","author":"P Hoffmann","year":"2006","unstructured":"Hoffmann P, Edinger M . CD4+CD25+ regulatory T cells and graft-versus-host disease. Semin Hematol 2006; 43: 62\u201369.","journal-title":"Semin Hematol"},{"key":"BF2404720_CR63","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.semcancer.2005.11.005","volume":"16","author":"T Yamaguchi","year":"2006","unstructured":"Yamaguchi T, Sakaguchi S . Regulatory T cells in immune surveillance and treatment of cancer. Semin Cancer Biol 2006; 16: 115\u2013123.","journal-title":"Semin Cancer Biol"},{"key":"BF2404720_CR64","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1002\/eji.200425143","volume":"34","author":"Q Tang","year":"2004","unstructured":"Tang Q, Boden EK, Henriksen KJ, Bour-Jordan H, Bi M, Bluestone JA . Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function. Eur J Immunol 2004; 34: 2996\u20133005.","journal-title":"Eur J Immunol"},{"key":"BF2404720_CR65","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<3137::AID-IMMU3137>3.0.CO;2-X","volume":"28","author":"CA Chambers","year":"1998","unstructured":"Chambers CA, Sullivan TJ, Truong T, Allison JP . Secondary but not primary T cell responses are enhanced in CTLA-4-deficient CD8+ T cells. Eur J Immunol 1998; 28: 3137\u20133143.","journal-title":"Eur J Immunol"},{"key":"BF2404720_CR66","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1084\/jem.189.7.1157","volume":"189","author":"KD McCoy","year":"1999","unstructured":"McCoy KD, Hermans IF, Fraser JH, Le Gros G, Ronchese F . Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) can regulate dendritic cell-induced activation and cytotoxicity of CD8(+) T cells independently of CD4(+) T cell help. J Exp Med 1999; 189: 1157\u20131162.","journal-title":"J Exp Med"},{"key":"BF2404720_CR67","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1182\/blood-2005-06-2298","volume":"106","author":"KD Lute","year":"2005","unstructured":"Lute KD, May Jr KF, Lu P, Zhang H, Kocak E, Mosinger B et al. Human CTLA4 knock-in mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti-CTLA-4 antibodies. Blood 2005; 106: 3127\u20133133.","journal-title":"Blood"},{"key":"BF2404720_CR68","doi-asserted-by":"publisher","first-page":"7276","DOI":"10.1158\/0008-5472.CAN-05-2128","volume":"66","author":"E Kocak","year":"2006","unstructured":"Kocak E, Lute K, Chang X, May Jr KF, Exten KR, Zhang H et al. Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunity. Cancer Res 2006; 66: 7276\u20137284.","journal-title":"Cancer Res"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2404720.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404720","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404720.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T10:32:42Z","timestamp":1707906762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2404720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,17]]},"references-count":68,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["BF2404720"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2404720","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,17]]},"assertion":[{"value":"7 December 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}